Apr 27, 2017 11:30 am UTC| Business
CAMBRIDGE, Mass., April 27, 2017 -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) and Aurigene Discovery Technologies Limited today announced a global license agreement to research, develop and commercialize small molecule...
NeuLion’s MainConcept Business Signs Multi-Codec Deal For Snell Advanced Media’s Broadcast Solutions
Apr 27, 2017 11:30 am UTC| Business
LAS VEGAS, NV, April 27, 2017 -- NeuLion, Inc. (TSX:NLN), a leading technology product and service provider specializing in the broadcasting, distribution and monetization of live and on-demand digital video content to...
Provision Holding to Present at Upcoming Joseph Gunnar & Co. Investor Conference
Apr 27, 2017 11:30 am UTC| Business
CHATSWORTH, Calif., April 27, 2017 -- Provision Holding, Inc. (OTCQB:PVHO), today announced that it will be presenting at Pioneers 2017 Conference, presented by Joseph Gunnar Co., on Tuesday, May 2nd at 10:30 a.m. The...
Agios to Webcast Conference Call of First Quarter 2017 Financial Results on May 4, 2017
Apr 27, 2017 11:25 am UTC| Business
CAMBRIDGE, Mass., April 27, 2017 -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced that the company will host a...
Navios Maritime Midstream Partners L.P. Reports Financial Results for the First Quarter of 2017
Apr 27, 2017 11:09 am UTC| Business
Net Income: $4.5 million in Q1EBITDA: $14.7 million in Q1Operating Surplus: $9.5 million in Q1Quarterly Cash Distribution of $0.4225 per unit; $1.69 per unit annualized100% of available days fixed through 2018Strong...
Apr 27, 2017 11:05 am UTC| Business
SALT LAKE CITY and BOULDER, Colo., April 27, 2017 -- Myriad Genetics, Inc. (NASDAQ:MYGN) and Clovis Oncology, Inc. (NASDAQ:CLVS) today announced a companion diagnostic collaboration to support a post-marketing...
Apr 27, 2017 11:03 am UTC| Business
DENVER, April 27, 2017 -- Bonanza Creek Energy, Inc. (NYSE:BCEI) (“Bonanza Creek” or the “Company”) today announced that the Company received approval to list its new common stock with the CUSIP number 097793 400 (the...